ABSTRACT
In this chapter, we discuss the analysis of microarray data derived from samples collected in clinical trials. In recent years, microarray technologies have been used extensively to study molecular differences among different types of cancer and these have played a fundamental role in identifying new drug leads with the further development of the biotech industry. Along with the development of microarray technology, many new statistical methods and models have been developed in parallel and incorporated in software to analyze highthroughput data.
